Beyond the Congress: ASCO21 /

Jennifer R. Brown, MD, PhD; Dana-Farber Cancer Institute #BtC_ASCO21

15:33

Dr. Jennifer Brown reviews Recently Presented Data of Clinical Trials and Standard of Care in Relapsed/Refractory CLL.

Beyond the Congress: ASCO21

Dr. Jennifer Brown reviews Recently Presented Data of Clinical Trials and Standard of Care in Relapsed/Refractory CLL.

Beyond the Congress: ASCO21 Similar Videos

Similar Videos

Selina Luger, MD, FRCPC; University of Pennsylvania #BtC_ASCO21

18:13

Dr. Selina Luger discusses Biomarkers and their Implications for Therapy in AML.
Alison J. Moskowitz, MD; Memorial Sloan Kettering Cancer Center #BtC_ASCO21

16:28

Dr. Alison Moskowitz presents on Treatments for Upfront and Relapsed Hodgkin’s Lymphoma.
Sagar Lonial, MD, FACP; Emory University #BtC_ASCO21

14:48

Dr. Sagar Lonial reviews Recently Presented Data of Clinical Trials and Standard of Care in Upfront Treatment for MM

ABOUT

Bio Ascend is an independent medical education company committed to supporting healthcare providers in their efforts to translate innovative science into clinical practice.

The Bio Ascend team has deep oncology and hematology expertise with a proven ability to distill complex scientific ideas into their essential components, as well as extensive experience in planning, executing, and assessing meaningful education for clinicians.

CONNECT

support@bioascend.com

(888) 476-9129

980 North Michigan Avenue, Suite 1400, Chicago, IL 60611